TDP-43 accumulation in inclusion body myopathy muscle suggests a common pathogenic mechanism with frontotemporal dementia
dc.contributor.author | Weihl C.C. | |
dc.contributor.author | Temiz P. | |
dc.contributor.author | Miller S.E. | |
dc.contributor.author | Watts G. | |
dc.contributor.author | Smith C. | |
dc.contributor.author | Forman M. | |
dc.contributor.author | Hanson P.I. | |
dc.contributor.author | Kimonis V. | |
dc.contributor.author | Pestronk A. | |
dc.date.accessioned | 2024-07-22T08:22:10Z | |
dc.date.available | 2024-07-22T08:22:10Z | |
dc.date.issued | 2008 | |
dc.description.abstract | TAR DNA binding protein-43 (TDP-43) is found in ubiquitinated inclusions (UBIs) in some frontotemporal dementias (FTD-U). One form of FTD-LJ, due to mutations in the valosin containing protein (VCP) gene, occurs with an inclusion body myopathy (IBMPFD). Since IBMPFD brain has TDP-43 in UBIs, we looked for TDP-43 inclusions in IBMPFD muscle. In normal muscle, TDP-43 is present in nuclei. In IBMPFD muscle, TDP-43 is additionally present as large inclusions within UBIs in muscle cytoplasm. TDP-43 inclusions were also found in 78% of sporadic inclusion body myositis (sIBM) muscles. In IBMPFD and sIBM muscle, TDP-43 migrated with an additional band on immunoblot similar to that reported in FTD-U brains. This study adds sIBM and hereditary inclusion body myopathies to the growing list of TDP-43 positive inclusion diseases. | |
dc.identifier.DOI-ID | 10.1136/jnnp.2007.131334 | |
dc.identifier.issn | 1468330X | |
dc.identifier.uri | http://akademikarsiv.cbu.edu.tr:4000/handle/123456789/18959 | |
dc.language.iso | English | |
dc.rights | All Open Access; Green Open Access | |
dc.subject | Adenosine Triphosphatases | |
dc.subject | Antigens, CD8 | |
dc.subject | Cell Cycle Proteins | |
dc.subject | Dementia | |
dc.subject | Diagnosis, Differential | |
dc.subject | DNA-Binding Proteins | |
dc.subject | Electromyography | |
dc.subject | Humans | |
dc.subject | Muscle, Skeletal | |
dc.subject | Mutation, Missense | |
dc.subject | Myositis, Inclusion Body | |
dc.subject | Phosphorylation | |
dc.subject | Point Mutation | |
dc.subject | DNA binding protein | |
dc.subject | TDP 43 | |
dc.subject | unclassified drug | |
dc.subject | article | |
dc.subject | brain | |
dc.subject | cytoplasm | |
dc.subject | frontotemporal dementia | |
dc.subject | human | |
dc.subject | human cell | |
dc.subject | human tissue | |
dc.subject | immunoblotting | |
dc.subject | inclusion body myopathy | |
dc.subject | inclusion body myositis | |
dc.subject | muscle | |
dc.subject | muscle cell | |
dc.subject | myopathy | |
dc.subject | pathogenesis | |
dc.subject | priority journal | |
dc.title | TDP-43 accumulation in inclusion body myopathy muscle suggests a common pathogenic mechanism with frontotemporal dementia | |
dc.type | Article |